Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions

A. Hoevenaren, L.F.D. van Vulpen, H. Levenga, M.C. Minnema, R.A.P. Raymakers

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)319-321
Number of pages3
JournalBone Marrow Transplantation
Volume46
Issue number2
DOIs
Publication statusPublished - Feb 2011

Keywords

  • Adult
  • Aged
  • Boronic Acids
  • Bortezomib
  • Disease-Free Survival
  • Female
  • Graft vs Host Disease
  • Graft vs Tumor Effect
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Lymphocyte Transfusion
  • Male
  • Middle Aged
  • Multiple Myeloma
  • Pyrazines
  • Recurrence
  • Retrospective Studies
  • Tissue Donors
  • Transplantation, Homologous
  • Letter

Cite this